Insybio

🎉 InSyBio team wishes you a happy New Year!

As we welcome 2026, we’re excited to reflect on an extraordinary year of scientific progress, innovative releases, and expanded collaborations here at InSyBio. 2025 was filled with meaningful advancements that strengthened our mission in precision medicine, systems biology, and AI-driven bioinformatics.

✨ Major Highlights from 2025
· Platform Evolution: We launched InSyBio Suite Version 3.4, delivering a major upgrade to the Interact tool for advanced protein interaction analysis and biological network discovery: https://suite.insybio.com/
· Collaborations: Partnering with Syndesis Health (https://syndesis.com/), we demonstrated the enormous value of training AI pipelines for medical applications using highly curated and validated clinical data. This collaboration has led to the development of digital diagnostic tools for cardiovascular diseases: https://diagnostics.insybio.com/
· Scientific Publications: Unravelling the human taste receptor interactome: machine learning and molecular modelling insights into protein-protein interactions. https://www.nature.com/articles/s41538-025-00478-9
· Research: InSyBio is actively participating in research projects focusing on applying its bioinformatics and predictive analysis expertise and technology in various fields, including research on human milk and resolving the molecular mechanisms of bone regeneration.
o GALATEA: https://galateahe.eu/
o OSTEONET: https://osteonethorizon.com/
o REGENERATION: https://regenerationhorizon.eu/
o REPLIFATE: https://replifate.eu/

🤗 Our Thanks:
Thank you to our collaborators, partners, clients, and the global research community. Your engagement and trust fuel our commitment to innovation. As we step into 2026, we look forward to even more discoveries, impactful tools, and collective progress in advancing human health.

Warm wishes for a happy, healthy, and successful New Year!

🚀 High-Quality Omics Analysis. Fixed Prices. Fast Turnaround.
At InSyBio, we’re launching Fixed-Price Micro-Analysis Services designed to help researchers, biotech companies, and academic groups turn omics data into actionable insights — quickly and transparently.
🧬 Our services include:
RNA-seq Standard Analysis (72h) — $289
RNA-seq Advanced & Multi-modal Integration — $689
Mass Spectrometry Proteomics (Standard & Advanced) — from $312
Biomarker Discovery (Multi-omics, AI/ML & Networks) — $599
ML-ready Data Cleaning & Feature Selection — $299
Grant Data Preparation Packages — $400–$800
✅ Every service includes:
-->1-hour intro call with our expert team
-->Up to 100 omics samples processed
-->Comprehensive analysis report
-->3 months access to results, figures & documentation
Need something custom? We also offer tailored omics analyses based on your project needs.
📩 Contact us: [email protected]

📅 Book a free 30-min consultation:
👉 https://lnkd.in/eNh3zYBj
Let’s turn your data into discoveries. 🔍✨

👋 Hello, and community!🚀InSyBio Suite Version 3.4 is here!

We’re excited to announce a major upgrade to InSyBio Interact, our advanced tool for protein analysis, protein–protein interaction ( ) exploration, functional annotation, and biological network creation.

With v3.4, researchers can:

🧬Access over 2 million positive and negative PPIs, including the complete interactomes of taste receptors and bone degeneration–related proteins from projects.

🧬Filter interactions using confidence and affinity thresholds and explore 75 computationally derived features with cross-references to major Databases.

🧬Perform in-depth protein analysis, retrieving structural, functional, and regulatory data (GO terms, miRNAs, and interaction partners).

🧬Discover computationally predicted protein complexes via the updated EEMC algorithm, with functional annotations and interactive visualization.

🧬Create and explore custom PPI datasets and full biological networks, all compatible with our interactive module.

💡 Why it matters: InSyBio Interact v3.4 unites high-accuracy PPI prediction, protein exploration, and network biology in a single, user-friendly platform. Researchers can move seamlessly from analyzing a single protein to mapping its role in complex , without the need for any coding expertise.

Read full announcement at: https://insybio.wordpress.com/2025/11/24/insybio-suite-version-3-4-is-announced-introducing-a-major-upgrade-of-the-insybio-interact-tool-for-advanced-protein-interaction-analysis-and-biological-network-discovery/

🎁 Request a free 1-month trial of InSyBio Suite here: https://insybio.com/get-a-free-one-month-license-of-insybio-suite/

InSyBio Suite Version 3.4 is announced, introducing a major upgrade of the InSyBio Interact tool for advanced protein interaction analysis and biological network discovery InSyBio is thrilled to announce the release of InSyBio Suite Version 3.4, with a major upgrade to the InSyBio Interact tool, an advanced environment for protein analysis, protein–protein interactio…

🔍 New Blog Post by Insybio 's data analyst Harry Zaverdas: Chronic Pain Management in the US & Europe

Chronic pain affects millions, yet care pathways remain fragmented across both regions. Our latest blog explores:

-->Key statistics on prevalence & costs
-->Differences in US vs. European treatment approaches
-->How data-driven, precision pain medicine could transform outcomes

Read the full article 👉 https://insybio.wordpress.com/2025/11/11/chronic-pain-management-in-usa-and-europe-current-status-and-open-challenges/

Chronic Pain Management in USA and Europe: Current status and open challenges Chronic Pain presents a major public health crisis and a leading source of human suffering and disability globally. Defined as the pain that persists or recurs for more than 3 months, its prevalenc…